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Abstract: Cats infected with the metastrongylid nematode Aelurostrongylus abstrusus may show clinical
signs ranging from mild to severe respiratory disease or remain unobserved, despite damages present in
the lung tissue. This study aimed to determine the seroprevalence and distribution of A. abstrusus in cats
by testing serum samples from all over Germany to identify potential risk areas and strengthen disease
awareness accordingly. Sera of 2998 cats were screened for the presence of antibodies against A. abstrusus
by ELISA, and the data were evaluated by a geographic information system to visualise the regional
distribution of the analysed samples. Overall, 12.0% of the samples tested positive (361/2998 cats, 95%
confidence interval: 10.9–13.3%). Seropositive cats were identified throughout the country, suggesting
that all cats in Germany with outdoor access are at risk of A. abstrusus infection and that the infection
is overall underdiagnosed. Increased testing for A. abstrusus infection would allow earlier detection of
infected animals, hence improving the life quality and health of cats and preventing potential death
under anaesthesia.
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1. Introduction
Aelurostrongylus abstrusus belongs to metastrongylid nematodes and is the most com-
mon feline lungworm worldwide being especially widespread across Europe [1]. Infected
animals may show a range of clinical signs, from asymptomatic to severe respiratory dis-
tress. The most frequently observed signs are chronic cough, sneezing, nasal discharge,
and dyspnea [2–5]. However, nonspecific signs or subclinical infections may also be ob-
served [6,7], potentially leading to undiagnosed or misdiagnosed infections. Clinically
apparent but asymptomatic infections with A. abstrusus should be considered seriously
because lung tissue may be heavily affected by verminous pneumonia [8,9], even during
prepatency [10]. Notably, such damages can lead to death during anaesthesia [11] and are
therefore equally relevant in the frame of routine surgeries such as spaying and neutering.
The analysis of faecal samples by the Baermann technique is still the most frequently
used diagnostic procedure to isolate and diagnose first-stage larvae (L1). This method
relies on living L1 and, therefore, on fresh samples, as it is based on the principle of
larval migration. Irregular or absent larval shedding, particularly in chronically and/or
repeatedly infected cats, represents a further limitation [12–14].
Alternative diagnostic options have been described, including microscopic and cy-
tologic examination of broncho-alveolar lavages [15], or, without anaesthesia, detecting
parasite DNA from faecal or pharyngeal swab samples by PCR [16]. In addition, serolog-
ical antibody detection was used recently for individual diagnosis and mass screening
of cat populations [17–19]. However, A. abstrusus antibodies may not only be present
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before patency (i.e., 15 days post-infection) but also persist for weeks after successful
anthelmintic treatment. In the latter case, antibody detection does not necessarily indicate
a current infection [19]. Nevertheless, experimental and field data suggest a higher detec-
tion rate by serological procedures compared with copromicroscopic methods [1,17,18,20],
which can be explained by earlier onset and more consistent persistence of antibodies than
larval production.
In the study presented here, we performed serological mass-screening of cats in Germany
by a validated ELISA [19] to detect A. abstrusus infections. Previous studies suggested potential
cross-reactions with other lungworms such as Troglostrongylus sp. [17,21,22]. In Germany,
however, the detection of lungworms other than A. abstrusus in cats is very rare, except for
Capillaria aerophila (syn. Eucoleus aerophilus). Prevalence data for A. abstrusus in Germany based
on copromicroscopic examinations range from 0.5% to 2.7%, and up to 6.6% in cats clinically
suspected of A. abstrusus infection [23–28]. In contrast, C. aerophila was identified at a high
prevalence (69.4%) in red foxes [29], but not in cats, except for a study where the prevalence
of Capillaria eggs was 1.0%, although these could not be confirmed as C. aerophila eggs [26].
The latter species was identified in German wild cats (Felis silvestris silvestris), along with
Troglostrongylus brevior and Angiostrongylus sp. [30], suggesting that these parasites occasionally
occur in wild felids in the country.
This study aimed to determine the seroprevalence and potential geographic risk areas
of A. abstrusus infection in cats by testing cat serum samples from all over the country
to support targeted disease awareness and promote appropriate diagnostic procedures
among veterinary practitioners.
2. Results
After analysing 2998 samples collected across Germany, an average seroprevalence
of 12.0% (361/2998 cats, 95% confidence interval [CI]: 10.9–13.3%) of A. abstrusus was
determined. Seropositive cats were identified throughout the country (Figure 1), and there
was a clear correlation between the number of analysed cats and the number of positive
cats, indicating that no area can be considered free of A. abstrusus.
A larger number of samples (>500) originated from Baden-Württemberg and Bavaria
in southern Germany and North-Rhine Westphalia, the most western federal state of the
country. In these regions, seroprevalences ranged from 9.0 to 14.8%, with an overlapping
95% CI (Table 1). Seroprevalences from other federal states ranged from 6.5% (Saxony-
Anhalt) to 32.0% (Mecklenburg-West Pomerania), with large 95% CIs. Therefore, no
statistical difference between the federal states was observed.
Table 1. Number of serologically examined seropositive cats in federal states of Germany.
Federal State of Germany Number of Examined Sera (n) Number of Positive Sera (n)
Seroprevalence and 95% Confidence
Intervals (%, Range)
Baden-Württemberg 546 64 11.7 (9.1–14.7)
Bavaria 548 77 14.1 (11.3–17.2)
Berlin 105 9 8.3 (4.0–15.6)
Brandenburg 110 14 12.7 (7.1–20.4)
Bremen 17 4 23.5 (6.8–49.9)
Hamburg 78 8 10.3 (4.5–19.2)
Hesse 252 23 9.1 (5.9–13.4)
Mecklenburg-West Pomerania 25 8 32.0 (14.9–53.5)
Lower Saxony 186 20 10.8 (6.7–16.1)
North-Rhine Westphalia 587 61 10.4 (8.0–13.1)
Rhineland Palatinate 133 12 9.0 (4.7–15.2)
Saarland 37 5 13.5 (4.5–28.8)
Saxony 138 19 13.8 (8.5–20.7)
Saxony-Anhalt 62 4 6.5 (1.8–15.7)
Schleswig-Holstein 122 19 15.6 (9.6–23.2)
Thuringia 52 14 26.9 (15.6–41.0)
Total 2998 361 12.0 (10.9–13.3)
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Figure 1. Occurrence of cats seropositive for antibodies against Aelurostrongylus abstrusus in Germany.
3. Discussion
With a seroprevalence of 12.0%, the rate of A. abstrusus antibody-positive cats in
Germany is clearly higher compared with previous data obtained by copromicroscopic
methods. Past studies, based on a similar selection of cat samples, where the Baermann
method was applied, indicated a prevalence of 2.7% in 3167 cats analysed between 1999
and 2002 [23], of 0.5% in 8560 cats analysed between 2003 and 2010 [26], and of 1.0% in 837
stray and foster cats sampled between 2006 and 2007 [27]. By contrast, selecting cats with
symptoms of respiratory disease, 5.6% of 231 and 6.6% of 391 cats were coproscopically
confirmed A. abstrusus positive between 2003 and 2007 [25], and between 2009 and 2011.
Overall, these results are comparable to data from Switzerland, a country bordering
the south of Germany: 10.7% of 4067 cats were seropositive for A. abstrusus antibodies [18],
whereas between 0.8% and 2.3% of cats were coproscopically positive, with a higher preva-
lence in stray cats (6.5%) than owned cats (0.7%) [1,31]. Experimental studies showed
that antibodies were detectable already 2–3 weeks before the onset of larval excretion [19],
although isolated individuals may seroconvert later than 10 weeks post-infection [32]. Anti-
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bodies were then shown to persist as long as worms were present, therefore not necessarily
correlating with patency [19]. Overall, a correlation between optical density (OD) values
and the number of L1 per gram of faeces was observed, and it was concluded that low larval
excretion may lead to OD values below the test threshold [32]. Antibodies also persisted
for weeks after anthelmintic treatment [19,32]. By contrast, chronically infected cats or cats
experiencing repeated infections (conceivable for all cats with unrestricted outdoor access)
particularly showed an absence of larval shedding [7,13,33], hence precluding diagnosis by
the Baermann method; this consequently leads to higher sensitivity and detection rates
obtained with serological testing. The latter observations have also been made within
highly endemic areas in Italy [17].
Our data indicate that the parasite is present in all German federal states. There were no sig-
nificant differences between the seroprevalences of the different federal states; however, within
single states, there are apparent areas with higher local endemicity, particularly where a high
number of samples were analysed (North-Rhine Westphalia, Baden-Württemberg and Bavaria).
Interestingly, these areas, together with the neighbouring state of Saarland, also showed higher
prevalence for canine lungworms Angiostrongylus vasorum and Crenosoma vulpis [34], both
sharing the same gastropod intermediate hosts with A. abstrusus [35]. Endemicity likely cor-
relates with the presence of intermediate hosts and, consequently, with a suitable climate for
coprophagic gastropods [18]. Different gastropod species are considered suitable intermediate
hosts for A. abstrusus, and, among them, Arion lusitanicus is a very common slug in central
Europe. Of note, 0.4% of 1587 analysed snails and slugs collected in four different sites in Ger-
many were A. abstrusus positive [35]. Since diverging risk and protective factors were identified
for different canine lungworms [34], additional factors influencing A. abstrusus occurrence are
expected. Wetlands and a higher density of wooded areas are considered advantageous for
A. abstrusus establishment, in contrast with an increased percentage of paved surfaces with a
loss of natural soil function, negatively influencing its occurrence, but altogether regionally in-
fluencing the number of available intermediate hosts [18]. Although it may be presupposed that
gastropods need a rather humid environment, epidemiological and geoclimatic studies showed
that A. abstrusus, with its large temperature tolerance, can establish itself worldwide. On one
hand, A. abstrusus L1 were shown to survive repeated freezing and thawing [36]. On the other
hand, warmer temperature conditions (18–29 ◦C) allowed a higher rate of larval development
in intermediate hosts [37], premising sufficient humidity. In an earlier coproscopic study, pos-
itive cats were identified in the above-mentioned federal states and in northern Germany,
but not in the centre of the country [28]. Therefore, increased A. abstrusus detection could
therefore reflect either an increase of parasite occurrence over the years or be related to the
low number of analysed samples between 2009–2011 [28]. Furthermore, considering the
limited mobility of gastropods, additional support for establishment and dispersion is pro-
vided by potential interposed paratenic hosts such as rodents (i.e., Apodemus agrarius) [38]
or reptiles, amphibians, and birds [39], probably feeding more frequently on gastropods
than cats themselves. Therefore, it can be summarised that all cats with outdoor access
may be at risk of infection in Germany, and in any A. abstrusus endemic area, provided that
the geoclimatic factors are favourable.
Although serology cannot discriminate current infections from recently dewormed
animals, the ELISA employed in the present work has the advantage of identifying positive
cats with few or even absent clinical signs and, partially, before patency [18]. Compared
with serology, a further disadvantage of L1 isolation from faecal samples is that it may be
challenging to obtain such samples from cats, especially from free-ranging animals at high
risk of infection. Further diagnostic tools may be used, reviewed in [40,41]. Diagnostic
imaging, i.e., radiology and computed tomography, illustrates the onset of such damages
despite the absence of clinical signs [8,32]. Infected cats may remain undetected by the
animal owner for some time, or the clinical signs may be attributed to another respiratory
disease, such as feline asthma, pulmonary oedema, neoplasia, or pneumonia-causing
pathogens [2,42]. In both cases, the additional risk for lethal outcome exists if cats are
subjected to anaesthesia: in 9% of cats whose death was associated with anaesthesia, lung
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tissue damages were caused by A. abstrusus [11]. Identifying infected cats by serology is
therefore useful and relevant in symptomatic and asymptomatic animals, especially in
view of the lung tissue damages induced by the parasite.
This risk is highly relevant considering that 12% of cats in Germany showed anti-
bodies against A. abstrusus and that cats are frequently neutered, treated for abscesses
or anesthetized for other reasons. Seroprevalences were actually almost twice as high in
cats of some investigated Mediterranean areas, including Greece (27.3%) and Italy (21.4%,
22.5%) [17,21,22]. Several factors influencing the risk of an individual cat becoming in-
fected with A. abstrusus, partially contradictory, were described [1,3,43,44]. In summary,
less well-cared-for cats with high roaming and hunting activity are at higher risk, directly
or indirectly influenced by their neutering status and age [18]. In addition, it cannot be
excluded that other infrequently occurring metastrongylid lungworms (Troglostrongylus sp.
and Angiostrongylus sp.) identified in wild cats of Germany [30] may also infect domestic
cats in the future, as observed in countries with higher endemicity. In Italy, a spillover from
wild cats to domestic cats was observed for T. brevior [2], while Angiostrongylus chabaudi or
Angiostrongylus vasorum is still very seldom found in domestic cats [45–47]. They all belong
to the same taxonomic family, have a comparable life cycle, and may result in serological
cross-reactions when testing for anti-A. abstrusus antibodies [17,21]. Capillaria spp. instead
belong to the trichurids and are, thus, taxonomically distant from the metastrongylids and
not expected to cross-react with them [19]. Therefore, serological detection of antibodies in
German cats is currently expected to indicate A. abstrusus infection.
A fundamental advantage of this study is the use of serology, allowing efficient mass
screening of cats; this is particularly valuable in the case of cats with outdoor access, where
cats must be confined for the collection of faecal samples and Baermann analysis. Thus, it
is easier for veterinary practitioners to collect a blood sample in case of clinical suspicion.
A limiting factor of the study is the lack of information regarding anamnestic data and
clinical signs of the investigated cats. However, advanced clinical signs often go undetected,
and our data confirm that the infection is underestimated overall. This work highlights the
benefit of increased testing for A. abstrusus infections in cats, with the goal of increasing
disease awareness for a more accurate and earlier identification of infected animals prone
to reduced quality of life and even death upon anaesthesia.
4. Materials and Methods
4.1. Cat Sera
Sera of 2998 cats from all over Germany submitted by veterinarians for haematological
or clinical chemistry analyses and various other medical reasons were collected between
November 2018 and March 2019. The sera were provided by IDEXX and sent to the Institute
of Parasitology, University of Zurich in Switzerland.
4.2. ELISA
Serum samples were stored at −20 ◦C and thawed before being tested for antibodies
against A. abstrusus by a previously described and validated indirect ELISA (sensitivity
88.2%, specificity 90.0%) [19]. The ELISA was performed with modifications: we used
Nunc Immobilizer Amino Plates (Thermo Fisher Scientific, Roskilde, Denmark) coated
with recombinant Dictyocaulus viviparus major sperm protein (MSP, 0.250 µg/well), serum
diluted 1:200, and a goat anti-feline IgG peroxidase-labelled conjugate (Southern Biotech,
Birmingham, AL, USA) at a dilution of 1:9000. The absorbance values were read in a
Multiscan ELISA reader (Tecan Infinite F50, Hombrechtikon, Switzerland), initially at
450 nm to determine the exact and optimal time to stop the reaction with sulphuric acid.
Subsequently, the plate was read at 492 nm. Each plate was run with a substrate control, two
positive controls (sera from experimentally infected cats), two negative controls (uninfected
laboratory cats) and a conjugate control. A reference serum was added twice to each plate
to calculate a correction factor for adjustment between plates [48]. Test threshold (0.295)
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was determined with 300 randomly selected samples based on the mean value of optical
density plus three standard deviations [49].
4.3. Mapping, Statistical Analyses
The collected data were analysed by a geographic information system (GIS) using the
program RegioGraph 10 (GfK GeoMarketing, Bruchsal, Germany) to visualise the regional
distribution of collected and analysed serum samples and A. abstrusus antibody-positive
samples. Based on four digits as points of reference, the locations of positive samples were
displayed on maps with administrative and postcode boundaries.
Excel 2016 for Windows (Microsoft Corporation, Redmond, WA, USA) was used
to calculate the prevalence values, the 95% CI and for calculating means and standard
deviations (SD).
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